We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mean Platelet Volume Determines Crimean-Congo Hemorrhagic Fever Prognosis

By LabMedica International staff writers
Posted on 28 Sep 2015
Print article
The ABBOTT CELL DYN RUBY Hematology Analyzer
The ABBOTT CELL DYN RUBY Hematology Analyzer (Photo courtesy of ABBOTT Corporate)
Crimean-Congo hemorrhagic fever virus (CCHF), a Nairovirus within the family Bunyaviridae, causes severe disease and pancytopenia, organ failures and disseminated intravascular coagulation may occur as a result of CCHF infection.

Changes in the mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in patients that have recovered from non-fatal CCHF can be predictors for the duration of hospitalization and prognosis.

Scientists at the Recep Tayyip Erdogan University (Rize, Turkey) studied a total of 50 CCHF patients including 27 males and 23 females and a similar age group of 47 healthy individuals including 27 males and 20 females) were included in the study. Hematologic and biochemical tests inclusive of C-reactive protein were conducted on patients and controls. Blood samples were checked for CCHF nucleic acids by real-time reverse transcriptase polymerase chain reaction (RT-PCR).

Biochemical tests were performed using photometric assays using the Abbott Architect c16000 analyzer (Abbott Diagnostics; Abbott Park, IL, USA). Hematological tests for hemoglobin, platelets, white blood cell counts (WBC), and MPV were performed using the Abbott Cell-Dyn Ruby analyzer. The C-reactive protein (CRP) test was performed using the nephelometric method in the Coulter Image 800 autoanalyzer (Beckman Coulter; Fullerton, CA, USA).

The MPV was statistically higher at 8.4 fL (range 6.4 to 9.4 fL) in patients than that of controls at 7.0 fL (range 6.0 to 8.7 fL). The NLR and PLR were similar in both groups. The predictors of the length of hospitalization included decreased white blood (WBC) cell and platelet counts, together with elevated prothrombin time (PT), creatinine and glucose levels. Bicytopenia and pancytopenia could also be seen in patients with CCHF. In severe cases, neutropenia and severe thrombocytopenia are also frequently encountered.

The authors concluded that the MPV was higher in patients, but NLR and PLR were similar in both groups. The MPV, NLR and PLR did not serve as predictors of hospitalization length. However, elevation of PT, creatinine, glucose, along with decreased WBC and platelets counts were found to be predictors of hospitalization period. The study was published in the September 2015 issue of Journal of Microbiology and Infectious Diseases.

Related Links:

Recep Tayyip Erdogan University
Abbott Diagnostics 
Beckman Coulter


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.